Immunizations in Adults: Essential Vaccines for Internal Medicine Practice

🔑 KEY CONCEPT: Adult immunization is a cornerstone of preventive medicine, significantly reducing morbidity and mortality from vaccine-preventable diseases. Unlike pediatric vaccination schedules, adult immunizations require individualized assessment based on age, health status, occupation, travel history, and risk factors.

Immunization Schedule Framework Adult vaccines are categorized into:

• Routine vaccines: Recommended for all adults (influenza, Td/Tdap)
• Age-based vaccines: Specific age groups (pneumococcal, zoster)
• Risk-based vaccines: High-risk conditions or exposures
• Travel vaccines: Destination-specific requirements

Contraindications and Precautions ⚠️ PEARL: Always screen for contraindications before vaccination:

• Severe immunodeficiency (live vaccines)
• Previous severe allergic reactions
• Acute moderate to severe illness
• Pregnancy (certain live vaccines)

Documentation and Tracking Maintain accurate vaccination records including:

• Vaccine type and lot number
• Administration date and site
• Vaccine information statement (VIS) date
• Next due date for boosters

Special Populations Immunocompromised patients require modified schedules:

• Higher doses for certain vaccines
• Avoid live vaccines
• Consider passive immunization
• Monitor antibody responses

Cost-Effectiveness Adult immunization provides excellent return on investment:

• Influenza vaccination prevents 1 hospitalization per 2,000 vaccinated adults
• Pneumococcal vaccination reduces invasive disease by 60-70%
• Zoster vaccination reduces incidence by 51% and post-herpetic neuralgia by 67%

🔬 DIAGNOSIS: Pneumococcal disease remains a leading cause of bacterial pneumonia, meningitis, and bacteremia in adults, with higher morbidity in elderly and immunocompromised patients.

Vaccine Types and Coverage

• PCV15 (Pneumococcal Conjugate Vaccine): Covers 15 serotypes
• PCV20 (Pneumococcal Conjugate Vaccine): Covers 20 serotypes
• PPSV23 (Pneumococcal Polysaccharide Vaccine): Covers 23 serotypes

⚡ HIGH-YIELD: PCV vaccines provide better immunogenicity and immunologic memory compared to PPSV23.

Current Recommendations (2024)

Age ≥65 years: ├── Previously unvaccinated │ └── Give PCV15 or PCV20 │ ├── If PCV15 given → PPSV23 ≥1 year later │ └── If PCV20 given → No further vaccination needed └── Previously received PPSV23 └── Give PCV15 or PCV20 ≥1 year after PPSV23

High-Risk Conditions (Ages 19-64) Indications for pneumococcal vaccination:

• Chronic heart, lung, liver, or kidney disease
• Diabetes mellitus
• Chronic alcoholism or smoking
• Immunocompromising conditions
• Cochlear implants or CSF leaks

Special Considerations

• Timing: Minimum 8-week interval between PCV and PPSV23
• Immunocompromised: May require additional PPSV23 doses
• Chronic kidney disease/nephrotic syndrome: Consider earlier vaccination
• Pregnancy: Generally avoided; vaccinate postpartum if indicated

💊 TREATMENT: For patients with recurrent pneumococcal infections despite vaccination, consider immunoglobulin deficiency evaluation.

🔑 KEY CONCEPT: Annual influenza vaccination is the most important intervention for preventing seasonal influenza and its complications, recommended for all persons ≥6 months without contraindications.

Vaccine Types (2024-2025 Season)

• Inactivated Influenza Vaccine (IIV): Standard, high-dose, adjuvanted
• Live Attenuated Influenza Vaccine (LAIV): Nasal spray (limited adult use)
• Recombinant Influenza Vaccine (RIV): Egg-free option

Age-Specific Recommendations

⚡ HIGH-YIELD: High-dose influenza vaccine (Fluzone High-Dose) contains 4x the antigen of standard vaccine and shows superior efficacy in adults ≥65 years.

Timing and Administration

• Optimal timing: September-October
• Latest recommendation: Continue vaccination as long as influenza viruses circulate
• Route: Intramuscular injection (deltoid preferred)
• Storage: Refrigerated (2-8°C), never freeze

Contraindications and Precautions Absolute contraindications:

• Severe allergic reaction to previous dose
• Severe egg allergy (for some vaccine types)

Relative contraindications for LAIV:

• Immunocompromised state
• Pregnancy
• Severe asthma or chronic lung disease
• Close contact with severely immunocompromised persons

High-Risk Groups Requiring Annual Vaccination ⚠️ PEARL: Emphasize vaccination for high-risk patients:

• Adults ≥65 years
• Chronic medical conditions (asthma, COPD, heart disease, diabetes)
• Immunocompromising conditions
• Pregnancy (any trimester)
• Healthcare personnel
• Caregivers of high-risk individuals

Effectiveness and Benefits

• Vaccine effectiveness: 40-60% when well-matched
• Reduces hospitalizations by 40% in elderly
• Decreases work absenteeism by 25-30%
• Provides community protection through herd immunity

💊 TREATMENT: Zoster vaccination prevents herpes zoster (shingles) and post-herpetic neuralgia, significantly reducing disease burden in older adults.

Current Vaccine: Recombinant Zoster Vaccine (RZV/Shingrix) RZV replaced live zoster vaccine (ZVL/Zostavax) as the preferred vaccine due to:

• Superior efficacy (>90% vs 51%)
• Longer duration of protection
• Safe in immunocompromised patients
• No live virus components

Indications and Recommendations

Zoster Vaccination Algorithm:

Age ≥50 years ├── Immunocompetent │ └── RZV 2-dose series (0, 2-6 months) ├── Immunocompromised ≥19 years │ └── RZV 2-dose series (consult specialist) └── Previous ZVL vaccination └── RZV 2-dose series ≥2 months after ZVL

Dosing Schedule

• Dose 1: Initial vaccination
• Dose 2: 2-6 months after first dose
• Route: Intramuscular injection (deltoid)
• Interchangeability: Complete series with RZV even if started with ZVL

🔬 DIAGNOSIS: Consider vaccination regardless of previous zoster episode, as recurrence is possible.

Immunocompromised Patients RZV is recommended for immunocompromised adults ≥19 years:

• HIV infection (CD4+ ≥200 cells/μL)
• Hematopoietic stem cell transplant (≥2 years post-transplant)
• Solid organ transplant
• Hematologic malignancies
• Solid tumors receiving chemotherapy
• Autoimmune diseases on immunosuppressive therapy

Contraindications

• Severe illness with fever
• Pregnancy or breastfeeding
• Severe immunodeficiency

Common Adverse Events ⚠️ PEARL: Prepare patients for common side effects:

• Injection site pain (78%)
• Muscle pain (45%)
• Fatigue (45%)
• Headache (38%)
• Fever (21%)

Cost-Effectiveness RZV vaccination provides substantial health benefits:

• Number needed to vaccinate: 12 to prevent one case of zoster
• Cost-effective in all adults ≥60 years
• Reduces healthcare utilization and lost productivity

🔑 KEY CONCEPT: Travel vaccination requires comprehensive risk assessment based on destination, duration, activities, season, and traveler characteristics. Pre-travel consultation should occur 4-6 weeks before departure.

Risk Assessment Framework

Travel Health Risk Assessment: ├── Destination factors │ ├── Endemic diseases │ ├── Outbreak status │ ├── Sanitation levels │ └── Healthcare quality ├── Traveler factors │ ├── Age and health status │ ├── Immunization history │ ├── Pregnancy status │ └── Immunocompromised state └── Trip factors ├── Duration of stay ├── Season of travel ├── Accommodation type └── Activities planned

Required vs. Recommended Vaccines

Common Travel Vaccines

Hepatitis A Vaccine

• Indications: Travel to endemic areas, MSM, illicit drug users
• Schedule: 2-dose series (0, 6-12 months)
• Efficacy: >95% after complete series
• Duration: Lifelong protection

Typhoid Vaccine ⚡ HIGH-YIELD: Two types available:

• Ty21a (oral): 4 capsules, live vaccine
• Vi polysaccharide (injection): Single dose
• Indications: Travel to endemic areas with poor sanitation
• Duration: 2-3 years protection

Yellow Fever Vaccine

• Indications: Required for travel to endemic areas (Africa, South America)
• Contraindications: Age >60 years (relative), immunosuppression
• Certificate: Valid 10 days after vaccination for life
• Adverse events: Risk of yellow fever vaccine-associated viscerotropic disease

Meningococcal Vaccines

• ACWY conjugate: Hajj pilgrimage requirement, college students
• Serogroup B: Specific outbreak areas
• Duration: 3-5 years protection

Japanese Encephalitis Vaccine

• Indications: Extended travel (>1 month) to rural Asia
• Schedule: 2-dose series (0, 28 days)
• Seasonal considerations: Transmission varies by region and season

Special Considerations 🔬 DIAGNOSIS: Document all travel vaccinations in International Certificate of Vaccination (yellow card).

• Pregnancy: Avoid live vaccines; risk-benefit analysis for inactivated vaccines
• Immunocompromised: Avoid live vaccines; may need higher doses
• Last-minute travel: Some vaccines effective within days

⚠️ PEARL: Immunocompromised patients require individualized vaccination strategies with emphasis on inactivated vaccines and careful timing around immunosuppressive therapy.

Categories of Immunocompromising Conditions

Live Vaccine Contraindications Absolutely contraindicated in:

• Severe immunodeficiency (primary or acquired)
• Active malignancy receiving treatment
• Recent HSCT (<24 months)
• High-dose corticosteroids (≥2 mg/kg/day or ≥20 mg/day for ≥14 days)
• Anti-TNF therapy and other biologics
• Recent immunoglobulin administration

Timing Considerations

Vaccination Timing in Immunocompromised Patients:

Before immunosuppression: ├── Inactivated vaccines: Give ≥2 weeks before └── Live vaccines: Give ≥4 weeks before

During immunosuppression: ├── Inactivated vaccines: Safe but may have reduced response └── Live vaccines: Generally contraindicated

After immunosuppression: ├── Restart routine schedule └── Consider revaccination for poor responders

Specific Populations

Diabetes Mellitus 💊 TREATMENT: Enhanced vaccination schedule:

• Annual influenza vaccine
• Pneumococcal vaccines per age-appropriate schedule
• Consider hepatitis B vaccination
• Routine Td/Tdap as scheduled

Chronic Kidney Disease/ESRD

• Hepatitis B: Higher doses (40 μg vs 20 μg) with anti-HBs monitoring
• Pneumococcal: Age-appropriate schedule with possible additional doses
• Influenza: Annual vaccination essential
• Pre-transplant: Complete all indicated vaccines

Healthcare Workers Mandatory/strongly recommended:

• Annual influenza vaccination
• Hepatitis B series with anti-HBs documentation
• MMR (if born ≥1957 without immunity evidence)
• Varicella (if no evidence of immunity)
• Td/Tdap every 10 years
• COVID-19 per institutional policy

Pregnancy and Vaccination Recommended during pregnancy:

• Tdap (27-36 weeks each pregnancy)
• Influenza (any trimester during flu season)
• COVID-19 per current recommendations

Contraindicated:

• Live vaccines (MMR, varicella, LAIV, live zoster)
• Travel vaccines requiring live virus

Response Monitoring 🔬 DIAGNOSIS: Consider serologic testing in immunocompromised patients:

• Hepatitis B: Anti-HBs levels
• Pneumococcal: Specific antibody responses
• Influenza: Generally not routinely tested
• Varicella: VZV IgG if vaccination history unclear

🔑 KEY CONCEPT: Proper vaccine administration, storage, and safety monitoring ensure optimal immunogenicity and minimize adverse events while maintaining public confidence in vaccination programs.

Vaccine Storage and Handling

⚠️ PEARL: Never freeze refrigerated vaccines - this destroys potency permanently.

Cold Chain Management

• Use calibrated thermometers with min/max readings
• Monitor temperatures twice daily
• Maintain temperature logs
• Have emergency procedures for equipment failure
• Use appropriate transport containers

Administration Techniques

Intramuscular Injection Sites: ├── Deltoid muscle (preferred for adults) │ ├── Needle length: 1-1.5 inches │ ├── Angle: 90 degrees │ └── Volume: Up to 1 mL └── Vastus lateralis (alternative) ├── Needle length: 1-1.5 inches ├── Angle: 90 degrees └── Volume: Up to 3 mL

Pre-vaccination Screening Always assess:

• Current illness status
• Allergy history (especially severe reactions)
• Immunocompromising conditions
• Pregnancy status
• Previous vaccination reactions
• Current medications
• Recent blood products or immunoglobulin

Contraindications vs. Precautions

💊 TREATMENT: Distinguish between absolute contraindications (do not vaccinate) and precautions (benefits vs. risks).

Absolute Contraindications:

• Severe allergic reaction to vaccine component
• Severe immunodeficiency (for live vaccines)
• Pregnancy (for most live vaccines)

Common Precautions:

• Moderate to severe acute illness
• Recent immunoglobulin administration
• Altered immunocompetence

Adverse Event Recognition and Reporting

⚡ HIGH-YIELD: Common adverse events by timing:

Vaccine Adverse Event Reporting System (VAERS)

• Report serious adverse events
• Required for certain events (Table of Reportable Events)
• Online reporting at vaers.hhs.gov
• Include vaccine lot numbers and timing

Managing Adverse Reactions

🔬 DIAGNOSIS: Emergency kit should include:

• Epinephrine auto-injectors
• Antihistamines (diphenhydramine)
• Corticosteroids
• Bronchodilators
• Equipment for airway management

Documentation Requirements

• Patient name and date of birth
• Vaccine type, manufacturer, lot number
• Expiration date
• Administration date and time
• Injection site and route
• VIS publication date
• Healthcare provider name/credentials

Quality Assurance

• Regular staff training updates
• Competency assessments
• Equipment calibration
• Policy review and updates
• Incident reporting systems